| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |